Fundraising FoxCultivation Capital Life Sciences
Venture capitalSt. Louis · 4 people tracked
Find your way into Cultivation Capital Life Sciences
Sign up to see every warm intro you have to Cultivation Capital Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cultivation Capital Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Cultivation Capital Life Sciences is a venture fund manager based in St. Louis. SEC filings show 1 venture fund on record, most recently Cultivation Capital Life Sciences Fund II, LLC ($30M offering) filed May 2020.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 4 people
from curated & public directories
Bill Schmidt leads Cultivation Capital's healthcare and life sciences strategy and has more than thirty years of experience in medical devices and healthcare IT. He cofounded and later sold the digital health company LDM Group, which built a software platform focused on behavioral adherence, and previously held executive roles at United States Surgical Corporation (now part of Medtronic) and Catalina Health Resource. He holds a B.S. in Electrical & Computer Engineering from the University of Wisconsin.
Rick Ryan has over 35 years of experience in business management and technology development within the life science industry, holding executive roles at both multinationals and early-stage ventures. He was VP of the Drug Discovery & Development business unit at Millipore until 2010 and previously served as President of LINCO Research and held Director-level positions at Monsanto. He currently serves as CEO of Apertus Pharmaceuticals, and holds a B.S. in Chemistry, a PhD in Biochemistry, and an executive MBA from Washington University in St. Louis.
Bobby Sandage is Managing Director at the Paula and Rodger Riney Foundation and Lightchain Capital, LLC, a General Partner in Cultivation Capital Life Sciences Fund II, and serves on the boards of Predicta Biosciences, Immunophotonics, and Endevica Bio. His earlier roles include President and CEO of Euclises and of Coronado Biosciences, VP of Embedded Therapeutics at Covidien Pharmaceuticals, and executive vice president of research and development and chief scientific officer at Indevus Pharmaceuticals, along with senior drug development positions at DuPont Merck Pharmaceutical Company and DuPont Critical Care. He is an adjunct professor of pharmaceutical sciences at the Southern Illinois University at Edwardsville School of Pharmacy, holds a Ph.D. in clinical pharmacy from Pur
Founder mafia
2 people who came through Cultivation Capital Life Sciences went on to found or lead other companies.
Frequently asked questions
- Where is Cultivation Capital Life Sciences located?
- Cultivation Capital Life Sciences is headquartered in St. Louis, US.